Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2024 10:00 ET | Source: Research and Markets

$12.5 Bn Influenza Vaccine Market to 2032 by Vaccine Type, Technology, Age Group, Route of Administration, and Region

Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Influenza Vaccine Market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032" report has been added to ...
July 12, 2024 07:00 ET | Source: FluGen, Inc.

FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows Superiority Over Flu Shot Alone

Combining FluGen's M2SR nasal spray flu vaccine with Sanofi's Fluzone High Dose shot generates superior results in older adults versus the shot alone.
January 31, 2024 09:18 ET | Source: Research and Markets

Global Influenza Vaccine Market Analysis & Forecast Report 2024: Advanced R&D Initiatives Poised to Catalyze Growth Through 2034

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccine Market Analysis & Forecast 2024-2034: Market By Vaccine Type; By Indication; By Age Group; By Route of Administration; By...
December 12, 2023 04:48 ET | Source: Research and Markets

FLUBLOK: A Quadrivalent Influenza Vaccine for Adults Aged 18 and Older - Drug Insights and Market Forecast to 2032

Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "FLUBLOK QUADRIVALENT...
November 24, 2023 09:08 ET | Source: Research and Markets

Fluzone Quadrivalent Drug Insights and Market Forecasts, 2019-2022 & 2023-2032

Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers...
December 04, 2020 03:58 ET | Source: Research and Markets

Seasonal Influenza Vaccines Market Report 2020: Flucelvax QIV and Flublok QIV are Expected to Experience Sales Growth Following Anticipated Regulatory Approvals in the EU in Q4 2020

Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The "Seasonal Influenza Vaccines" report has been added to ResearchAndMarkets.com's offering. The seasonal influenza vaccines market in the US, Japan, and...